Bayraktar Y, Balkanci F, Uzunalimoglu B, Gokoz A, Koseoglu T, Batman F, Gurakar A, Van Thiel D H, Kayhan B
Department of Gastroenterology, School of Medicine, Hacettepe University, Ankara, Turkey.
Am J Gastroenterol. 1996 Mar;91(3):554-8.
The gastric mucosa of patients with portal hypertension frequently manifests changes in its appearance that are readily identifiable by endoscopy. Many of these can be sources of bleeding, and some imply the presence of systemic disease. Although portal hypertension is critical in development of portal hypertensive gastropathy (PHG), the role that other factors might play in its pathogenesis is uncertain.
Four groups of subjects were studied prospectively: 37 with portal hypertension due to cirrhosis, 26 noncirrhotic subjects with portal hypertension due to extrahepatic portal vein obstruction (PVO), nine cirrhotic patients with extrahepatic PVO, and 57 control subjects. The diagnosis in each case was based on a combination of clinical data, needle liver biopsy, ultrasonography, splenoportography, and upper GI endoscopy.
Snake skin, scarlatina rash, diffuse hyperemia, and diffuse bleeding were frequent endoscopic gastric findings in cirrhotic patients. These findings were seen less frequently in noncirrhotic patients with portal hypertension due to PVO than in cirrhotic patients (p< 0.0001). The highest incidence was seen in cirrhotic patients with PVO (P< 0.001). Positive correlations existed among the endoscopic findings, the clinical estimate of the cirrhosis severity (Child-Pugh grade), and the size and appearance of esophageal varices (Beppu score). No endoscopic findings of the gastric mucosa enabled one to distinguish between groups. Hypergastrinemia was present in cirrhotics with and without PVO but not in noncirrhotic patients with portal hypertension resulting from isolated PVO.
These findings suggest that the endoscopic findings of PHG are affected by the severity of the underlying liver disease and the presence or absence of coexisting PVO. There is no association between PHG and the presence of gastric varices. Thus, the development of the gastric lesions characteristic of PHG requires not only portal hypertension but also some other consequence of parenchymal liver disease.
门静脉高压患者的胃黏膜常表现出在内镜下易于识别的外观变化。其中许多变化可能是出血的来源,有些则提示存在全身性疾病。尽管门静脉高压在门静脉高压性胃病(PHG)的发生中起关键作用,但其他因素在其发病机制中可能发挥的作用尚不确定。
前瞻性研究了四组受试者:37例因肝硬化导致门静脉高压的患者、26例因肝外门静脉阻塞(PVO)导致门静脉高压的非肝硬化患者、9例患有肝外PVO的肝硬化患者以及57例对照受试者。每例患者的诊断均基于临床数据、肝脏穿刺活检、超声检查、脾门静脉造影和上消化道内镜检查的综合结果。
蛇皮样改变、猩红热样皮疹、弥漫性充血和弥漫性出血是肝硬化患者内镜下常见的胃部表现。在因PVO导致门静脉高压的非肝硬化患者中,这些表现的出现频率低于肝硬化患者(p<0.0001)。在患有PVO的肝硬化患者中发生率最高(P<0.001)。内镜检查结果、肝硬化严重程度的临床评估(Child-Pugh分级)以及食管静脉曲张的大小和外观(Beppu评分)之间存在正相关。胃黏膜的内镜检查结果无法区分各组。伴有或不伴有PVO的肝硬化患者均存在高胃泌素血症,但孤立性PVO导致门静脉高压的非肝硬化患者中不存在高胃泌素血症。
这些发现表明,PHG的内镜检查结果受潜在肝脏疾病的严重程度以及是否存在并存的PVO的影响。PHG与胃静脉曲张的存在无关。因此,PHG特征性胃部病变的发生不仅需要门静脉高压,还需要实质性肝脏疾病的其他一些后果。